The schistosome enzyme that activates oxamniquine has the characteristics of a sulfotransferase

Available evidence suggests that the antischistosomal drug oxamniquine is converted to a reactive ester by a schistosome enzyme that is missing in drug-resistant parasites. This study presents data supporting the idea that the active ester is a sulfate and the activating enzyme is a sulfotransferase...

Full description

Bibliographic Details
Main Authors: Livia Pica-Mattoccia, Daniele Carlini, Alessandra Guidi, Velasco Cimica, Fabio Vigorosi, Donato Cioli
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2006-10-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762006000900048